CD8+ T cells drive neuroinflammation and cognitive decline in Alzheimer’s disease
It is believed that in-depth exploration of the immunoregulatory mechanisms of CD8 + T cells in AD can provide theoretical foundations and new perspectives for developing innovative immunotherapies targeting neuroinflammation and cognitive impairment in AD.